News for IM Cannabis Corp. (IMCC.CN)

Trading activity for IM Cannabis (IMCC) has recommenced, drawing the attention of investors eager to assess the company's market performance. This development o

Trading for IM Cannabis (IMCC) was temporarily halted following a volatility trading pause. Such halts are typically enacted to stabilize trading when there are

PR NewswireTORONTO and GLIL YAM, Israel, May 27, 2025 THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO

IM Cannabis (IMCC) completed the Focus Transaction, settling NIS 818,740 by issuing 128,818 shares at C$2.44 each. The company raised C$2.3 million thro

IM Cannabis Corp. (NASDAQ:IMCC) Q1 2025 Earnings Call May 15, 2025 9:00 AM ETCompany ParticipantsAnna Taranko - Director, Investor and Public RelationsOren...

PR NewswireTORONTO and GLIL YAM, Israel, May 15, 2025 IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational

IM Cannabis Corp. (NASDAQ: IMCC) reported a net profit of $175,000 for Q1 2025, marking a significant financial turnaround. The company saw a 94% year-o

PR NewswireTORONTO and GLIL YAM, Israel, May 7, 2025 TORONTO and GLIL YAM, Israel, May 7, 2025 /PRNewswire/ -- IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC)

IM Cannabis Corp. (Nasdaq: IMCC) plans to acquire a 26% interest in Focus, valued at approximately NIS 818,740, through an issuance of common shares. Th

PR NewswireTORONTO and GLIL YAM, Israel, May 6, 2025 TORONTO and GLIL YAM, Israel, May 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC)

PR NewswireTORONTO and GLIL YAM, Israel, April 11, 2025 TORONTO and GLIL YAM, Israel, April 11, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ:

A company has been informed by Nasdaq on April 9 that it is not in compliance with the Nasdaq Listing Rule 5550(b)(1). This rule mandates that companies on the

IM Cannabis Corp. (NASDAQ: IMCC) has received a Nasdaq notification for non-compliance with the minimum stockholders' equity requirement of US$2.5 million.

IM Cannabis Corp. (NASDAQ:IMCC) Q4 2024 Earnings Conference Call March 31, 2025 9:00 AM ETCompany ParticipantsAnna Taranko - Director of Investor and Public...

PR NewswireTORONTO and GLIL YAM, Israel, March 20, 2025 TORONTO and GLIL YAM, Israel, March 20, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ:

Ironwood Pharmaceuticals (IRWD) recently experienced a significant stock price drop of 5.20%, bringing its share price to $3.58. The trading volume reached 431,

IM Cannabis Announces Change of Auditors

Regencell Bioscience Holdings Ltd (RGC), a company specializing in traditional Chinese medicine for neurological and cognitive disorders, experienced a signific

Cumberland Pharmaceuticals (CPIX) experienced significant stock movement with a 5.40% surge. The stock is currently priced at $1.17 per share, with a trading vo